Former Chief Medical Officer · ALX ONCOLOGY HOLDINGS INC (ALXO)

Sophia Randolph

A named executive officer of ALX ONCOLOGY in every fiscal year CompBrief holds from FY2019 to FY2024. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2024

$3,530,138

Salary $468,922Stock awards $1,425,600

FY2023: $1,374,892

2nd of 6 named executive officers at ALX Oncology by FY2024 total.

6 named officers on file for ALX ONCOLOGY, FY2024

Sophia Randolph’s pay file — $29

  • 6 fiscal years of pay, line by line
  • 4 equity grants, each cited to its filing
  • ALXO’s disclosed peer group of 20 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how ALX ONCOLOGY’s whole pay program stands against its peers

  • ALX ONCOLOGY’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on ALXO→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 21, 2025 (DEF 14A).

Free

Get Sophia Randolph’s full pay file as a PDF — free

More than this page: up to 10 years of Sophia’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Sophia Randolph compensation by year

ALX ONCOLOGY Summary Compensation Table · all 6 fiscal years held
In US dollars, as ALX ONCOLOGY reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2019FY2020FY2021FY2022FY2023FY2024
Salary$351,100$397,588$453,200$471,330$510,000$468,922
Bonus$0$350,000$0$0$0$0
Stock awards$0$0$0$424,390$199,240$1,425,600
Option awards$40,834$1,818,862$4,116,990$1,022,942$461,652$1,131,736
Non-equity incentive$105,400$190,915$181,280$165,908$204,000$0
Pension and deferred compensation$0$0$0$0$0$0
All other$0$0$0$0$0$503,880
Total$497,334$2,757,365$4,751,470$2,084,570$1,374,892$3,530,138

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: ALX ONCOLOGY HOLDINGS INC DEF 14A filed April 21, 2025, accession 0000950170-25-056291, and prior-year filings.

How this page was built: the ALX ONCOLOGY HOLDINGS INC filed document, accession 0000950170-25-056291. Every figure is read from that document and cited to the page and table it appears in. Filed April 21, 2025.

$497K
$2.8M
$4.8M
$2.1M
$1.4M
$3.5M
FY19
FY20
FY21
FY22
FY23
FY24
SalaryBonusNon-equity incentiveStock awardsOption awardsAll other

ALX ONCOLOGY’s named executive officers, FY2024

as the company reported each
Named executive officerRoleFY2024 total
Jason LettmannChief Executive Officer$6,640,830
Sophia Randolph · this pageFormer Chief Medical Officer$3,530,138
Jaume PonsFormer President and Chief Scientific Officer$3,017,955
Peter GarciaFormer Chief Financial Officer$2,697,079
Shelly PintoSenior Vice President, Finance and Chief Accounting Officer$1,505,161
Shelly WongSenior Vice President, Finance and Chief Accounting Officer$1,505,161

Board service

ALX ONCOLOGY board · FY2023

How this board is paid

Company policy: ALX ONCOLOGY pays directors a $40,000 cash retainer. As stated in ALX ONCOLOGY's FY2023 proxy.

The full ALX ONCOLOGY compensation record

free company brief

This page is one person within ALX ONCOLOGY's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the ALX ONCOLOGY proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are ALX ONCOLOGY's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Sophia Randolph's compensation dossier · One-time report. No refunds.